X4 Pharmaceuticals (XFOR) Earnings Date & Reports

X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

XFOR is expected to report earnings to fall 320.75% to -8 cents per share on July 31

X4 Pharmaceuticals XFOR Stock Earnings Reports

Q2'25

Est.

$-0.09

Q1'25

Beat

by $0.16

Q4'24

Missed

by $0.04

Q3'24

Missed

by $0.01

Q2'24

Beat

by $0.46

The last earnings report on May 01 showed earnings per share of 3 cents, beating the estimate of -11 cents. With 41.32K shares outstanding, the current market capitalization sits at 19.04M.

View a ticker or compare two or three

Compare

XFOR